Understanding Takayasu Arteritis: An Introduction
At a Glance
Takayasu arteritis is a rare immune-related inflammation of the aorta and its major branches. It can thicken or scar artery walls, narrowing blood flow or causing aneurysms, so diagnosis relies on symptoms, imaging, and specialist assessment.
If you have just heard the words Takayasu Arteritis (pronounced TAH-kah-YAH-soo ar-te-RY-tis) for the first time, it is normal to feel overwhelmed. This is a very rare condition with a complex name, but at its core, it is a well-defined medical issue that doctors have studied for over a century. Named after Dr. Mikito Takayasu, who first described its characteristic vascular changes in 1908, it is a type of vasculitis—a family of conditions where the immune system mistakenly attacks the walls of the blood vessels [1][2].
Validation of your emotions is an important first step. Being diagnosed with a disease that many people (and even some general practitioners) have never heard of can feel isolating. However, you are entering a community of patients and specialists who understand this condition and have clear frameworks for managing it.
Defining Large Vessel Vasculitis
To understand this condition, it helps to visualize the circulatory system of your body. Your heart pumps blood into a massive main artery called the aorta. From there, large branches carry blood to your head, arms, and organs.
Takayasu Arteritis is classified as a large vessel vasculitis because it primarily affects the aorta and these major branches [1][3].
- Inflammation: Your immune system sends cells into the layers of the artery wall [4].
- Wall Changes: This inflammation can cause the walls of the arteries to thicken or become scarred (fibrosis) [5].
- Blood Flow: As the walls thicken, the space inside the artery (the lumen) can narrow, which is called stenosis. In some cases, the wall may weaken and bulge outward, forming an aneurysm [4][5].
Because it involves the largest blood vessels in the body, it is a serious condition that requires specialized care, but modern imaging and treatments allow doctors to monitor these changes closely and intervene to protect your circulation [1].
Understanding Rarity and Demographics
One of the most daunting aspects of Takayasu Arteritis is its rarity. Globally, the incidence (the rate of newly diagnosed cases) is estimated at roughly 1 to 2 people per million each year [6][7].
Geographic Variation
While it is found in every part of the world, the overall prevalence (the total number of people living with it) is more commonly reported in certain regions. For example:
- Asia: Studies in Japan and Korea show higher prevalence rates, with some estimates reaching 28 to 40 cases per million people [8][9].
- Europe and North America: The condition is less common here, with prevalence estimates ranging from approximately 1 to 33 per million depending on the specific country and study method [7][10].
- Other Regions: Recent data from Brazil shows a prevalence of about 17 per million [11].
Who is typically affected?
Takayasu Arteritis is often called “young female arteritis” because it most frequently affects women in their 20s and 30s [12][10]. However, this is not a strict rule. Men are also diagnosed with the condition, and while the typical age of onset is between 20 and 40, it can be diagnosed in children or in older adults [12][9]. Your specific ancestry and age might influence how the disease presents, but the underlying process of vessel inflammation remains the same [10].
How Doctors Classify the Condition
Because the symptoms can be vague early on, doctors use specific criteria to help structure their assessment. The most recent guidelines, released in 2022 by the American College of Rheumatology (ACR) and EULAR, use a point-based system [13][14].
It is incredibly important to understand that these are research classification criteria designed to ensure that patients in clinical trials have the same condition; they are not a diagnostic test, nor a score of how sick you are. To be considered for this specific research classification, a patient generally must be 60 years old or younger at the time of diagnosis and have imaging showing large-vessel vasculitis. Points are then added based on symptoms (like limb claudication or a blood pressure difference) or imaging findings.
Crucially, a clinical diagnosis is different. Your doctor may diagnose you with Takayasu Arteritis even if you are over 60, or if you do not meet the strict research score, provided your symptoms and imaging are consistent with the disease [15]. Please do not attempt to self-score.
You are not just a statistic or a rare case; you are a person with a manageable vascular condition. By working with a team of specialists—typically rheumatologists and vascular specialists—you can create a plan to keep your circulation healthy and your immune system in check.
Common questions in this guide
What exactly is Takayasu arteritis?
Who is most likely to develop Takayasu arteritis?
What symptoms can Takayasu arteritis cause?
Does meeting the Takayasu arteritis classification score confirm the diagnosis?
Which doctors usually care for Takayasu arteritis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What imaging was used to confirm my diagnosis, and which specific vessels are involved?
- 2.Is there evidence of active inflammation in my vessel walls right now, or am I seeing the results of past damage?
- 3.Given my ancestry and age, how does my case compare to the typical patterns you see in your practice?
- 4.What is the primary goal of my treatment plan over the next six months?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (15)
- 1
Aortitis and aortic aneurysm in systemic vasculitis.
Tyagi S, Safal S, Tyagi D
Indian journal of thoracic and cardiovascular surgery 2019; (35(Suppl 2)):47-56 doi:10.1007/s12055-019-00832-z.
PMID: 33061066 - 2
Medium- and Large-Vessel Vasculitis.
Saadoun D, Vautier M, Cacoub P
Circulation 2021; (143(3)):267-282 doi:10.1161/CIRCULATIONAHA.120.046657.
PMID: 33464968 - 3
Advances in the pathophysiology, diagnosis and treatment of Takayasu arteritis.
Sawalha AH, Misra DP, Goel R, et al.
Nature reviews. Rheumatology 2025; (21(12)):737-751 doi:10.1038/s41584-025-01309-7.
PMID: 41198934 - 4
Sudden death due to Takayasu arteritis complication associated with situs inversus totalis: A case discovered at autopsy.
Ben Jomaa S, El Aini I, Chebbi E, et al.
Journal of forensic and legal medicine 2023; (96()):102527 doi:10.1016/j.jflm.2023.102527.
PMID: 37094461 - 5
Takayasu Arteritis.
Russo RAG, Katsicas MM
Frontiers in pediatrics 2018; (6()):265 doi:10.3389/fped.2018.00265.
PMID: 30338248 - 6
A systematic review and meta-analysis of the incidence rate of Takayasu arteritis.
Rutter M, Bowley J, Lanyon PC, et al.
Rheumatology (Oxford, England) 2021; (60(11)):4982-4990 doi:10.1093/rheumatology/keab406.
PMID: 33944899 - 7
Epidemiology of Takayasu arteritis.
Onen F, Akkoc N
Presse medicale (Paris, France : 1983) 2017; (46(7-8 Pt 2)):e197-e203 doi:10.1016/j.lpm.2017.05.034.
PMID: 28756072 - 8
Epidemiology of Takayasu arteritis in Shanghai: A hospital-based study and systematic review.
Sun Y, Yin MM, Ma LL, et al.
International journal of rheumatic diseases 2021; (24(10)):1247-1256 doi:10.1111/1756-185X.14183.
PMID: 34314100 - 9
Incidence, prevalence, mortality and causes of death in Takayasu Arteritis in Korea - A nationwide, population-based study.
Park SJ, Kim HJ, Park H, et al.
International journal of cardiology 2017; (235()):100-104 doi:10.1016/j.ijcard.2017.02.086.
PMID: 28283361 - 10
Prevalence, Incidence, and Disease Characteristics of Takayasu Arteritis by Ethnic Background: Data From a Large, Population-Based Cohort Resident in Southern Norway.
Gudbrandsson B, Molberg Ø, Garen T, Palm Ø
Arthritis care & research 2017; (69(2)):278-285 doi:10.1002/acr.22931.
PMID: 27159262 - 11
The Epidemiology of Takayasu Arteritis in Rio de Janeiro, Brazil: A Large Population-Based Study.
Vieira M, Ochtrop MLG, Sztajnbok F, et al.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2023; (29(5)):e100-e103 doi:10.1097/RHU.0000000000001964.
PMID: 37068270 - 12
Current Clinical Features of New Patients With Takayasu Arteritis Observed From Cross-Country Research in Japan: Age and Sex Specificity.
Watanabe Y, Miyata T, Tanemoto K
Circulation 2015; (132(18)):1701-9 doi:10.1161/CIRCULATIONAHA.114.012547.
PMID: 26354799 - 13
2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis.
Grayson PC, Ponte C, Suppiah R, et al.
Annals of the rheumatic diseases 2022; (81(12)):1654-1660 doi:10.1136/ard-2022-223482.
PMID: 36351705 - 14
2022 American College of Rheumatology/EULAR Classification Criteria for Takayasu Arteritis.
Grayson PC, Ponte C, Suppiah R, et al.
Arthritis & rheumatology (Hoboken, N.J.) 2022; (74(12)):1872-1880 doi:10.1002/art.42324.
PMID: 36349501 - 15
Validation and clinical application of 2022 ACR/EULAR criteria for Takayasu arteritis in a large Chinese cohort.
Gao J, He S, Liu Y, et al.
Rheumatology (Oxford, England) 2025; (64(11)):5826-5833 doi:10.1093/rheumatology/keaf372.
PMID: 40644612
This introduction is for educational purposes and does not replace medical advice. A rheumatologist or vascular specialist should interpret your symptoms and imaging and discuss your individual care plan.
Get notified when new evidence is published on Takayasu arteritis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.